Pear Bio Alternatives & Competitors
12 companies similar to Pear Bio — Patient-centered cancer precision medicine
Companies similar to Pear Bio
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key d...
Wilmington, United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Boston, United States
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Rival Readout
Competing with Pear Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
-logo.jpg "Ikena Oncology (Merged with ImageneBio)"){kind=logo}
Ikena Oncology (Merged with ImageneBio)
Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for mo...
Boston, United States
Celsius Therapeutics
On a quest to leverage the power of single cell genomics to discover novel drug targets an...
Cambridge, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Cambridge, United States
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Lynx Biosciences, Inc.
Resolving cancer biology through integrated multi-omics.
San Diego, United States
Treeline
Making medicines at the highest level
Watertown, United States
About Pear Bio
Pear Bio, founded in 2017 and headquartered in the United Kingdom, is making strides in the fields of Biotechnology and Health Care with its focus on Patient-centered cancer precision medicine. The company employs a proprietary computational biology platform to unravel intricate cancer biology, facilitating both patien...
Personalized Testing Services, Drug Discovery
Cancer Patients, Oncologists, Biopharmaceutical Companies, Medical Researchers
Precision Medicine, Cancer Biology, Functional Genomics, 3D Microtumor Platforms, Computational Biology, Drug Discovery, Biomarker Development, AI In Oncology, Ex Vivo Testing, Multi-omics, Immune-Microtumors, Patient-Centric Therapies, Image-Based Biomarkers, 3D Computer Vision, Therapeutic Development
B2B, B2B2C
Service Fee, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Pear Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Pear Bio on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
